Results 41 to 50 of about 1,786 (140)

External Genital Cutaneous Sarcoidosis Mimicking Lichen Sclerosus

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Although external genital cutaneous sarcoidosis is rare, it can closely resemble lichen sclerosus (LS) and delay diagnosis. We report a case of a 69‐year‐old woman with long‐standing vulvar symptoms and LS‐like pallor of the labia minora and clitoris. Biopsy showed non‐caseating granulomas with negative infection stains, consistent with vulvar
Enakshi Mudalige, Annabel Stevenson
wiley   +1 more source

Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study

BMC Women's Health, 2021
Background Vulvo-vaginal atrophy (VVA) is one of the common consequences of estrogen deficiency especially after the menopause. Several studies have assessed the effects of Hyaluronic acid (HA) on physical and sexual symptoms associated with VVA with ...
Nicolas Berreni, Jennifer Salerno, Thierry Chevalier, Sandrine Alonso, Pierre Mares   +4 more
doaj   +1 more source

Evaluation of symptoms and prevention of cancer in menopause: the value of vulvar exam [PDF]

, 2016
Vulvar and vaginal atrophy (VVA), is a chronic medical condition experienced by postmenopausal women, with prevalence estimated ranging from 10% to 50% [1]. VVA is characterized by a constellation of symptoms, that may affect daily activities, sexuality,
Guida, Maurizio, Gargano, Virginia, Santoro, Giuseppe, Fasolino, Carmine, Rinaldi, Maurizio, Arduino, Bruno, Palumbo, Anna Rita, Belli, Mario   +7 more
core   +1 more source

Impact of Human Papillomavirus Primary Cervical Screening on Referral Rates and Outcomes for People Referred to Colposcopy for Clinical Reasons

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 5, October 2026.
ABSTRACT Colposcopy is most commonly indicated for people with screen‐positive cervical screening tests. However, clinical reasons such as post‐coital bleeding (PCB) or an abnormal appearing cervix can also prompt referral. Aotearoa New Zealand (AoNZ) transitioned from a cytology‐based to an HPV‐based cervical screening programme in September 2023 ...
Adibah Khan, Katyana Gullery, Georgina Barber, Judy Ormandy   +3 more
wiley   +1 more source

Clinical, Biochemical and Pathological Findings in Symptomatic and Asymptomatic Bitches With Intrauterine Content

Reproduction in Domestic Animals, Volume 61, Issue S3, October 2026.
ABSTRACT Intrauterine contents are a common ultrasound finding in bitches, with variable significance. Clinical, analytical and histopathological findings were compared between symptomatic and asymptomatic bitches with intrauterine contents that underwent ovariohysterectomy. In this cross‐sectional study, the majority were symptomatic (87.9%, 123/140).
María Victoria Falceto, Ana María Garrido, Alba Garrigós, María Borobia, Bernardino Moreno, María Teresa Tejedor, Cristina Albisu, Laura Garza‐Moreno, Julia Cantin, Olga Mitjana   +9 more
wiley   +1 more source

Urethral Resection and Neo-Urethra in Invasive Vulvar Cancer

Gynecology Obstetrics & Reproductive Medicine
Vulvar cancer is a significant gynecological malignancy. It often invades surrounding organs at the time of diagnosis. In cases of urethral invasion, lack of effective reconstruction may result in serious micturition disorders.
Hasan Gungor, Ibrahim Topcu
doaj   +1 more source

Survey on Aesthetic Vulvovaginal Procedures: What do PortugueseDoctors andMedical Students Think? [PDF]

Revista Brasileira de Ginecologia e Obstetrícia, 2017
Objective To assess themedical doctors andmedical students’ opinion regarding the evidence and ethical background of the performance of vulvovaginal aesthetic procedures (VVAPs).
Pedro Vieira-Baptista, Joana Lima-Silva, José Fonseca-Moutinho, Virgínia Monteiro, Fernanda Águas   +4 more
doaj   +1 more source

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy

, 2014
OBJECTIVE: Assessment of 12-month safety of ospemifene 60 mg/day for treatment of postmenopausal women with vulvar and vaginal atrophy (VVA).METHODS: In this 52-week, randomized, double-blind, placebo-controlled, parallel-group study, women 40-80 years ...
Portman, D J, Lin, V H, Blaakær, Jan; id_orcid, Goldstein, S R, Koninckx, P R, Ylikorkala, O, Bachmann, G A, Ravn, Pernille; id_orcid   +7 more
core   +1 more source

Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age

International Journal of Gynecology &Obstetrics, Volume 174, Issue 3, Page 1151-1171, September 2026.
Abstract Recent advances in cancer screening, diagnosis, and treatment have greatly improved survival rates among women with gynecologic cancers. More survivors now live long enough to experience treatment‐related menopause. Vasomotor symptoms, genitourinary syndrome of menopause, sexual dysfunction, sleep issues, and long‐term risks from estrogen ...
Agnaldo Lopes da Silva‐Filho, Suvarna Khadilkar, Hema Divakar, Chiara Benedetto, Andrea R. Genazzani, Diana Ramos, Elizabete Argale, Enrique Herrera, Martha Hickey   +8 more
wiley   +1 more source

Efficacy of Vaginal Laser Treatment for Symptomatic Relief of Vulvovaginal Atrophy in Postmenopausal Women [PDF]

, 2021
Introduction: As women age and go through menopause, the decrease in estrogen that occurs with this process causes many changes in the body, one being atrophy of the vaginal skin, The thinning and drying of the vaginal canal as well as the external ...
Parker, Kathleen
core   +1 more source